Publications by authors named "Gurleen Singh Jhuti"
Page 1 of 1
Synopsis of recent research by authors named "Gurleen Singh Jhuti"
- Gurleen Singh Jhuti's research primarily focuses on the treatment and cost-effectiveness of adjuvant trastuzumab emtansine (T-DM1) for patients with HER2-positive early breast cancer, particularly those with residual disease following neoadjuvant therapy.
- One significant study predicted the population-level impact of T-DM1 on the incidence of metastatic breast cancer in multiple countries, suggesting that its use could potentially reduce disease recurrence or death among women in these regions.
- Another analysis assessed the cost-effectiveness of T-DM1 compared to trastuzumab in the United States, utilizing a Markov cohort-based model to evaluate long-term clinical and economic outcomes, indicating a favorable economic position for T-DM1 in treating this patient population.
